Pubblicazioni

Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms?

2021 - FRONTIERS IN ENDOCRINOLOGY
Giannetta, E.; La Salvia, A.; Rizza, L.; Muscogiuri, G.; Campione, S.; Pozza, C.; Colao, A. A. L.; Faggiano, A.

Exocrine pancreatic insufficiency and somatostatin analogs in patients with neuroendocrine neoplasia

2021 - EXPERT OPINION ON DRUG SAFETY
Panzuto, F.; Magi, L.; Rinzivillo, M.

Efficacy of lutetium-peptide receptor radionuclide therapy in inducing prolonged tumour regression in small-bowel veuroendocrine tumours. A case of favourable response to retreatment after Initial objective response

2021 - ONCOLOGY RESEARCH AND TREATMENT
Rinzivillo, M.; Prosperi, D.; Bartolomei, M.; Panareo, S.; Iannicelli, E.; Magi, L.; Panzuto, F.

Thymic carcinomas and thymic neuroendocrine tumors. A tribute to Dr. Juan Rosai

2021 - PATHOLOGICA
Di Tommaso, L.; Pescarmona, E.; Di Napoli, A.; Lauriola, L.; Marino, M.; Marx, A.; Strobel, P.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma